Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362692051> ?p ?o ?g. }
- W4362692051 endingPage "e0282680" @default.
- W4362692051 startingPage "e0282680" @default.
- W4362692051 abstract "Background & aims Immunotherapy represents the new standard of care in systemic first-line treatment of hepatocellular carcinoma (HCC). Biomarkers that predict treatment response and survival remain an unmet clinical need. Methods Patients with HCC treated with immune-checkpoint inhibitors (ICI) between 10/2017 and 03/2022 were retrospectively evaluated. Immunoglobulin levels (IgG, IgM, IgA) were measured at baseline and six weeks after initiation of ICI treatment. Impact of relative changes on overall survival (OS), progression-free survival (PFS), and time to progression (TTP) were evaluated. Results Seventy-two patients with HCC receiving ICI (mostly atezolizumab/bevacizumab n = 54,75%) were included (mean age: 68±12 years, cirrhosis: 72%, mean Child-Turcotte-Pugh [CTP] score: 7±2 points). Most patients had a preserved performance status (ECOG-PS 0, n = 45, 63%), 25 (35%) showed macrovascular invasion, and 32 (44%) had extrahepatic spread. Baseline immunoglobulin values (median, IgG: 1395mg/dL, IgM: 337mg/dL, IgA: 89mg/dL) were not different between responders and non-responders, and neither baseline nor follow-up immunoglobulin values correlated with OS, PFS, and TTP. However, the relative change in IgG (Δ-IgG) independently predicted OS in multivariable Cox regression analysis after adjusting for severity of liver disease, baseline AFP and CRP as well as for Δ-IgA and Δ-IgM. Patients could be stratified into high (Δ-IgG≥+14%) vs. low (Δ-IgG<+14%) risk groups (median OS: 6.4 vs. 15.9 months; p = 0.001). Importantly, Δ-IgG was also associated with PFS and TTP on adjusted multivariable Cox regression analyses. Conclusion Our study proposes a higher increase of Δ-IgG upon ICI treatment as a negative prognostic marker in patients with HCC, independent of underlying liver disease severity. These results require independent validation." @default.
- W4362692051 created "2023-04-09" @default.
- W4362692051 creator A5001144757 @default.
- W4362692051 creator A5006745092 @default.
- W4362692051 creator A5019346703 @default.
- W4362692051 creator A5024485263 @default.
- W4362692051 creator A5048534007 @default.
- W4362692051 creator A5055058026 @default.
- W4362692051 creator A5084197662 @default.
- W4362692051 creator A5087316703 @default.
- W4362692051 creator A5090751499 @default.
- W4362692051 date "2023-04-07" @default.
- W4362692051 modified "2023-09-25" @default.
- W4362692051 title "Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients" @default.
- W4362692051 cites W1974226124 @default.
- W4362692051 cites W2039689494 @default.
- W4362692051 cites W2079586464 @default.
- W4362692051 cites W2091600198 @default.
- W4362692051 cites W2252919733 @default.
- W4362692051 cites W2318933482 @default.
- W4362692051 cites W2342028809 @default.
- W4362692051 cites W2417099837 @default.
- W4362692051 cites W2559517375 @default.
- W4362692051 cites W2626033245 @default.
- W4362692051 cites W2767554904 @default.
- W4362692051 cites W2919097179 @default.
- W4362692051 cites W3008867523 @default.
- W4362692051 cites W3044786201 @default.
- W4362692051 cites W3094178633 @default.
- W4362692051 cites W3094602125 @default.
- W4362692051 cites W3128694153 @default.
- W4362692051 cites W3152534107 @default.
- W4362692051 cites W3180754516 @default.
- W4362692051 cites W3205914248 @default.
- W4362692051 cites W3213277274 @default.
- W4362692051 cites W3216692809 @default.
- W4362692051 cites W4245784696 @default.
- W4362692051 doi "https://doi.org/10.1371/journal.pone.0282680" @default.
- W4362692051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37027398" @default.
- W4362692051 hasPublicationYear "2023" @default.
- W4362692051 type Work @default.
- W4362692051 citedByCount "0" @default.
- W4362692051 crossrefType "journal-article" @default.
- W4362692051 hasAuthorship W4362692051A5001144757 @default.
- W4362692051 hasAuthorship W4362692051A5006745092 @default.
- W4362692051 hasAuthorship W4362692051A5019346703 @default.
- W4362692051 hasAuthorship W4362692051A5024485263 @default.
- W4362692051 hasAuthorship W4362692051A5048534007 @default.
- W4362692051 hasAuthorship W4362692051A5055058026 @default.
- W4362692051 hasAuthorship W4362692051A5084197662 @default.
- W4362692051 hasAuthorship W4362692051A5087316703 @default.
- W4362692051 hasAuthorship W4362692051A5090751499 @default.
- W4362692051 hasBestOaLocation W43626920511 @default.
- W4362692051 hasConcept C10515644 @default.
- W4362692051 hasConcept C121608353 @default.
- W4362692051 hasConcept C126322002 @default.
- W4362692051 hasConcept C143998085 @default.
- W4362692051 hasConcept C159654299 @default.
- W4362692051 hasConcept C203014093 @default.
- W4362692051 hasConcept C2775949291 @default.
- W4362692051 hasConcept C2777214474 @default.
- W4362692051 hasConcept C2777546739 @default.
- W4362692051 hasConcept C2777701055 @default.
- W4362692051 hasConcept C2778019345 @default.
- W4362692051 hasConcept C2780030458 @default.
- W4362692051 hasConcept C2780898057 @default.
- W4362692051 hasConcept C50382708 @default.
- W4362692051 hasConcept C71924100 @default.
- W4362692051 hasConcept C90924648 @default.
- W4362692051 hasConceptScore W4362692051C10515644 @default.
- W4362692051 hasConceptScore W4362692051C121608353 @default.
- W4362692051 hasConceptScore W4362692051C126322002 @default.
- W4362692051 hasConceptScore W4362692051C143998085 @default.
- W4362692051 hasConceptScore W4362692051C159654299 @default.
- W4362692051 hasConceptScore W4362692051C203014093 @default.
- W4362692051 hasConceptScore W4362692051C2775949291 @default.
- W4362692051 hasConceptScore W4362692051C2777214474 @default.
- W4362692051 hasConceptScore W4362692051C2777546739 @default.
- W4362692051 hasConceptScore W4362692051C2777701055 @default.
- W4362692051 hasConceptScore W4362692051C2778019345 @default.
- W4362692051 hasConceptScore W4362692051C2780030458 @default.
- W4362692051 hasConceptScore W4362692051C2780898057 @default.
- W4362692051 hasConceptScore W4362692051C50382708 @default.
- W4362692051 hasConceptScore W4362692051C71924100 @default.
- W4362692051 hasConceptScore W4362692051C90924648 @default.
- W4362692051 hasIssue "4" @default.
- W4362692051 hasLocation W43626920511 @default.
- W4362692051 hasLocation W43626920512 @default.
- W4362692051 hasOpenAccess W4362692051 @default.
- W4362692051 hasPrimaryLocation W43626920511 @default.
- W4362692051 hasRelatedWork W2100744225 @default.
- W4362692051 hasRelatedWork W2785808209 @default.
- W4362692051 hasRelatedWork W2802256694 @default.
- W4362692051 hasRelatedWork W2988525911 @default.
- W4362692051 hasRelatedWork W3091367366 @default.
- W4362692051 hasRelatedWork W3206932502 @default.
- W4362692051 hasRelatedWork W3215044659 @default.
- W4362692051 hasRelatedWork W4280643539 @default.